22763-65-1 Usage
Uses
Used in Pharmaceutical Industry:
1-(2-PIPERIDINOETHYL)PIPERAZINE is used as a building block in the synthesis of pharmaceuticals for its ability to contribute to the development of new organic compounds with therapeutic properties.
Used as an Anticancer Agent:
1-(2-PIPERIDINOETHYL)PIPERAZINE is used as a potential anticancer agent due to its capacity to target and combat cancer cells, offering a promising avenue for cancer treatment.
Used in Antipsychotic and Antidepressant Research:
1-(2-PIPERIDINOETHYL)PIPERAZINE is used as a compound in the study of its potential as an antipsychotic and antidepressant, highlighting its possible role in mental health treatments.
Used as a Corrosion Inhibitor:
1-(2-PIPERIDINOETHYL)PIPERAZINE is used in the field of material protection as a potential corrosion inhibitor, serving to extend the lifespan and integrity of various materials.
Used as an Antimicrobial Agent:
1-(2-PIPERIDINOETHYL)PIPERAZINE is used in the development of antimicrobial agents, leveraging its properties to combat microbial growth and infections.
Check Digit Verification of cas no
The CAS Registry Mumber 22763-65-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,7,6 and 3 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 22763-65:
(7*2)+(6*2)+(5*7)+(4*6)+(3*3)+(2*6)+(1*5)=111
111 % 10 = 1
So 22763-65-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H23N3/c1-2-6-13(7-3-1)10-11-14-8-4-12-5-9-14/h12H,1-11H2
22763-65-1Relevant academic research and scientific papers
3-PHENYLSULPHONYL-QUINOLINE DERIVATIVES AS AGENTS FOR TREATING PATHOGENIC BLOOD VESSELS DISORDERS
-
, (2021/04/23)
The disclosure provides compounds, and compositions, including pharmaceutical compositions, kits that include the compounds, and methods of using (or administering) and making the compounds. The disclosure further provides compounds or compositions thereof for use in a method of modulating PLXDC1 (TEM7) and/or PLXDC2 or killing pathogenic blood vessles. The disclosure further provides compounds or compositions thereof for use in a method of treating a disease, disorder, or condition that is mediated, at least in part, by PEDF receptors or by angiogenesis.
Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents
Liang, Yu-Kun,Yue, Zhi-Zhou,Li, Jia-Xin,Tan, Cun,Miao, Ze-Hong,Tan, Wen-Fu,Yang, Chun-Hao
, p. 505 - 515 (2014/08/05)
Two series of novel 2-substituted 5,7-dihydroxyanthra[2,1-d]thiazole-6,11- dione derivatives from natural rhein were designed, synthesized and evaluated for their antitumour activities against human cancer cell lines A549 and HeLa in vitro.
Piperazine derivatives with anticholinergic and/or antihistaminic activity
-
, (2008/06/13)
Compounds of formula I STR1 are described in which R is an aryl, substituted aryl, aralkyl or heterocyclic radical; R1 is hydrogen or alkyl of 1-4 carbon atoms; A is a saturated, aliphatic hydrocarbon chain, which is linear or branched; R2
